Two CRLs lat­er, Illi­nois-based CD­MO hit with FDA warn­ing let­ter over 's­pore-form­ing' bac­te­ria and fun­gi

Dupo, IL-based con­tract man­u­fac­tur­er Ster­ling Phar­ma­ceu­ti­cals has had a long, tough year.

Last Sep­tem­ber, part­ner Ver­ri­ca Phar­ma­ceu­ti­cals’ NDA for a po­ten­tial skin dis­ease treat­ment was …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER